Table 4.
Pairwise comparison for emotion regulation variable
| Group | Measure | Time (I) | Time (J) | Mean difference (I−J) | Standard error | Sig. | 95% Confidence interval | |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Lower bound | Upper bound | |||||||
| tDCS + medication | ES | Pretest | Posttest | −1.133 | 1.534 | 1.000 | −5.345 | 3.078 |
| Follow-up | −0.333 | 1.213 | 1.000 | −3.664 | 2.997 | |||
| Posttest | Pretest | 1.133 | 1.534 | 1.000 | −3.078 | 5.345 | ||
| Follow-up | 0.800 | 1.082 | 1.000 | −2.171 | 3.771 | |||
| Follow-up | Posttest | 0.333 | 1.213 | 1.000 | −2.997 | 3.664 | ||
| Follow-up | −0.800 | 1.082 | 1.000 | −3.771 | 2.171 | |||
| CR | Pretest | Posttest | −8.400* | 1.783 | 0.001 | −13.297 | −3.503 | |
| Follow-up | −7.600* | 2.170 | 0.012 | −13.559 | −1.641 | |||
| Posttest | Pretest | 8.400* | 1.783 | 0.001 | 3.503 | 13.297 | ||
| Follow-up | 0.800 | 0.954 | 1.000 | −1.820 | 3.420 | |||
| Follow-up | Pretest | 7.600* | 2.170 | 0.012 | 1.641 | 13.559 | ||
| Posttest | −0.800 | 0.954 | 1.000 | −3.420 | 1.820 | |||
| Total | Pretest | Posttest | −11.000* | 1.663 | 0.000 | −15.568 | −6.432 | |
| Follow-up | −8.400* | 2.751 | 0.028 | −15.955 | −0.845 | |||
| Posttest | Pretest | 11.000* | 1.663 | 0.000 | 6.432 | 15.568 | ||
| Follow-up | 2.600 | 2.232 | 0.795 | −3.529 | 8.729 | |||
| Follow-up | Pretest | 8.400* | 2.751 | 0.028 | 0.845 | 15.955 | ||
| Posttest | −2.600 | 2.232 | 0.795 | −8.729 | 3.529 | |||
| Medication | ES | Pretest | Posttest | 0.200 | 1.429 | 1.000 | −3.725 | 4.125 |
| Follow-up | 3.333 | 1.757 | 0.241 | −1.491 | 8.158 | |||
| Posttest | Pretest | −0.200 | 1.429 | 1.000 | −4.125 | 3.725 | ||
| Follow-up | 3.133 | 1.621 | 0.226 | −1.318 | 7.585 | |||
| Follow-up | Pretest | −3.333 | 1.757 | 0.241 | −8.158 | 1.491 | ||
| Posttest | −3.133 | 1.621 | 0.226 | −7.585 | 1.318 | |||
| CR | Pretest | Posttest | −1.067 | 1.161 | 1.000 | −4.254 | 2.121 | |
| Follow-up | 4.133* | 1.127 | 0.009 | 1.039 | 7.228 | |||
| Posttest | Pretest | 1.067 | 1.161 | 1.000 | −2.121 | 4.254 | ||
| Follow-up | 5.200* | 1.536 | 0.015 | 0.982 | 9.418 | |||
| Follow-up | Pretest | −4.133* | 1.127 | 0.009 | −7.228 | −1.039 | ||
| Posttest | −5.200* | 1.536 | 0.015 | −9.418 | −0.982 | |||
| Total | Pretest | Posttest | −1.467 | 2.013 | 1.000 | −6.994 | 4.061 | |
| Follow-up | 6.800* | 1.490 | 0.002 | 2.707 | 10.893 | |||
| Posttest | Pretest | 1.467 | 2.013 | 1.000 | −4.061 | 6.994 | ||
| Follow-up | 8.267* | 2.342 | 0.011 | 1.836 | 14.697 | |||
| Follow-up | Pretest | −6.800* | 1.490 | 0.002 | −10.893 | −2.707 | ||
| Posttest | −8.267* | 2.342 | 0.011 | −14.697 | −1.836 | |||
ES, expressive suppression; CR, cognitive reappraisal; tDCS, transcranial Direct Current Stimulation; Sig., significant.
*The mean difference is significant at p < 0.05.